{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T17:55:32Z","timestamp":1775930132927,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ajpm-online.net","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.amepre.2024.08.007","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T23:22:27Z","timestamp":1723850547000},"page":"12-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cost-Effectiveness of Varicella Vaccination for 1\u20134-Year-Olds in Shanghai, China"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8561-8929","authenticated-orcid":false,"given":"Baichu","family":"Guan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7313-5330","authenticated-orcid":false,"given":"Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7546-0114","authenticated-orcid":false,"given":"Zhuoying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7845-3753","authenticated-orcid":false,"given":"Jia","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4651-9433","authenticated-orcid":false,"given":"Yihan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.amepre.2024.08.007_bib0001","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/v10110609","article-title":"Clinical features of varicella-zoster virus infection","volume":"10","author":"Kennedy","year":"2018","journal-title":"Viruses-Basel"},{"issue":"9544","key":"10.1016\/j.amepre.2024.08.007_bib0002","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","article-title":"Varicella","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.amepre.2024.08.007_bib0003","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.amepre.2024.08.007_bib0004","first-page":"95","article-title":"Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies","volume":"41","author":"Freer","year":"2018","journal-title":"New Microbiologica"},{"issue":"3","key":"10.1016\/j.amepre.2024.08.007_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2015.06.004","article-title":"Varicella-zoster virus infections of the central nervous system - prognosis, diagnostics and treatment","volume":"71","author":"Grahn","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.amepre.2024.08.007_bib0006","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1093\/infdis\/jiy403","article-title":"Immunobiology of Varicella-Zoster virus infection","volume":"218","author":"Laing","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amepre.2024.08.007_bib0007","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2334-12-140","article-title":"Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population","volume":"12","author":"van Rijckevorsel","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.amepre.2024.08.007_bib0008","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijid.2013.10.003","article-title":"Changing seroprevalence of varicella zoster virus infection in a tropical city state, Singapore","volume":"22","author":"Fatha","year":"2014","journal-title":"Int J Infect Dis"},{"issue":"52","key":"10.1016\/j.amepre.2024.08.007_bib0009","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.46234\/ccdcw2023.218","article-title":"Epidemiological Characteristics of Varicella Outbreaks - China, 2006-2022","volume":"5","author":"Wang","year":"2023","journal-title":"China Cdc Weekly"},{"issue":"2","key":"10.1016\/j.amepre.2024.08.007_bib0010","first-page":"123","article-title":"[The investigation on economic burden with outpatient of varicella in Shandong, Gansu and Hunan provinces in 2007]","volume":"15","author":"Yin","year":"2009","journal-title":"Zhongguo Yi Miao He Mian Yi"},{"issue":"10","key":"10.1016\/j.amepre.2024.08.007_bib0011","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz410","article-title":"Factors influencing the size and duration of school varicella outbreaks in Shanghai, China, in the era of voluntary single-dose vaccination","volume":"6","author":"Wu","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.amepre.2024.08.007_bib0012","doi-asserted-by":"crossref","DOI":"10.1177\/0300060519887847","article-title":"A persistent outbreak of varicella in a primary school in Dongguan City, Guangdong Province, China","volume":"48","author":"Zhong","year":"2020","journal-title":"J Int Med Res"},{"key":"10.1016\/j.amepre.2024.08.007_bib0013","doi-asserted-by":"crossref","first-page":"100639","DOI":"10.1016\/j.lanwpc.2022.100639","article-title":"National and provincial burden of varicella disease and cost-effectiveness of childhood varicella vaccination in China from 2019 to 2049: a modelling analysis","volume":"32","author":"Feng","year":"2023","journal-title":"Lancet Regional Health-Western Pacific"},{"issue":"6","key":"10.1016\/j.amepre.2024.08.007_bib0014","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/0063030-200822060-00005","article-title":"Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix\u2122)","volume":"22","author":"Kreth","year":"2008","journal-title":"Biodrugs"},{"issue":"3","key":"10.1016\/j.amepre.2024.08.007_bib0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/21645515.2018.1546525","article-title":"Global impact of varicella vaccination programs","volume":"15","author":"Varela","year":"2019","journal-title":"Human Vaccines Immunotherap"},{"issue":"12","key":"10.1016\/j.amepre.2024.08.007_bib0016","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3390\/vaccines9121485","article-title":"Has clinical and epidemiological varicella burden changed over time in children? Overview on hospitalizations, comorbidities and costs from 2010 to 2017 in Italy","volume":"99","author":"Piazza","year":"2021","journal-title":"Vaccines"},{"issue":"25","key":"10.1016\/j.amepre.2024.08.007_bib0017","first-page":"265","article-title":"Varicella and herpes zoster vaccines: WHO position paper, June 2014","volume":"89","year":"2014","journal-title":"Releve epidemiologique hebdomadaire"},{"key":"10.1016\/j.amepre.2024.08.007_bib0018","unstructured":"Vaccination schedule for Varicella. World Health Organization website. https:\/\/immunizationdata.who.int\/. Accessed March 30,2024"},{"issue":"2","key":"10.1016\/j.amepre.2024.08.007_bib0019","first-page":"169","article-title":"Varicella vaccine coverage levels among 1-14-year-old children in China in 2020:a crosssectional survey","volume":"28","author":"Hu","year":"2022","journal-title":"Chin J Vaccines Immunization"},{"issue":"6","key":"10.1016\/j.amepre.2024.08.007_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270630","article-title":"Varicella outbreaks in schools and kindergartens in Shanghai, China from 2011 to 2020","volume":"17","author":"Wang","year":"2022","journal-title":"Plos One"},{"issue":"3","key":"10.1016\/j.amepre.2024.08.007_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282327","article-title":"Systematic review of economic evaluations of varicella vaccination programmes","volume":"18","author":"Anderson","year":"2023","journal-title":"Plos One"},{"issue":"7","key":"10.1016\/j.amepre.2024.08.007_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254080","article-title":"Clinical and economic impact of universal varicella vaccination in Norway: a modeling study","volume":"16","author":"Pawaskar","year":"2021","journal-title":"Plos One"},{"key":"10.1016\/j.amepre.2024.08.007_bib0023","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/CEOR.S229685","article-title":"The cost-effectiveness of universal varicella vaccination in Italy: a model-based assessment of vaccination strategies","volume":"12","author":"Azzari","year":"2020","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.amepre.2024.08.007_bib0024","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1086\/522135","article-title":"An economic analysis of the universal varicella vaccination program in the United States","volume":"197","author":"Zhou","year":"2008","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.amepre.2024.08.007_bib0025","doi-asserted-by":"crossref","first-page":"E3617","DOI":"10.1093\/cid\/ciaa1708","article-title":"Epidemiological impact and cost-effectiveness of varicella vaccination strategies in the United Kingdom","volume":"73","author":"Akpo","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.amepre.2024.08.007_bib0026","doi-asserted-by":"crossref","first-page":"E217","DOI":"10.1097\/INF.0000000000003136","article-title":"Health impact and cost-effectiveness assessment for the introduction of universal varicella vaccination in Switzerland","volume":"40","author":"Heininger","year":"2021","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.amepre.2024.08.007_bib0027","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/vaccines10091416","article-title":"Modeling the impact of exogenous boosting and universal varicella vaccination on the clinical and economic burden of varicella and herpes zoster in a dynamic population for England and Wales","volume":"10","author":"Sharomi","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.amepre.2024.08.007_bib0028","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/s12889-015-1861-8","article-title":"Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries","volume":"15","author":"Damm","year":"2015","journal-title":"Bmc Public Health"},{"issue":"4","key":"10.1016\/j.amepre.2024.08.007_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001743","article-title":"Universal varicella vaccination in Denmark: Modeling public health impact, age-shift, and cost-effectiveness","volume":"3","author":"Burgess","year":"2023","journal-title":"PLOS Global Public Health"},{"issue":"1","key":"10.1016\/j.amepre.2024.08.007_bib0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jval.2020.10.004","article-title":"What we know now: an economic evaluation of chickenpox vaccination and dose timing using an agent-based model","volume":"24","author":"Rafferty","year":"2021","journal-title":"Value in Health"},{"issue":"5","key":"10.1016\/j.amepre.2024.08.007_bib0031","doi-asserted-by":"crossref","first-page":"2045152","DOI":"10.1080\/21645515.2022.2045152","article-title":"Cost effectiveness and budget impact of universal varicella vaccination in Russia","volume":"18","author":"Marijam","year":"2022","journal-title":"Human Vaccines Immunotherap"},{"issue":"8","key":"10.1016\/j.amepre.2024.08.007_bib0032","doi-asserted-by":"crossref","first-page":"e0220921","DOI":"10.1371\/journal.pone.0220921","article-title":"Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model","volume":"14","author":"Wolfson","year":"2019","journal-title":"Plos One"},{"key":"10.1016\/j.amepre.2024.08.007_bib0033","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/ijpvm.IJPVM_295_16","article-title":"Cost-effectiveness of varicella vaccination program in Iran","volume":"8","author":"Esmaeeli","year":"2017","journal-title":"Int J Prevent Med"},{"issue":"2","key":"10.1016\/j.amepre.2024.08.007_bib0034","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.vaccine.2012.10.100","article-title":"How cost effective is universal varicella vaccination in developing countries? A case-study from Colombia","volume":"31","author":"Paternina-Caicedo","year":"2013","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.amepre.2024.08.007_bib0035","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1080\/21645515.2021.1958608","article-title":"Economic evaluation of varicella vaccination strategies in Jiangsu province, China: a decision-tree Markov model","volume":"17","author":"Wang","year":"2021","journal-title":"Human Vaccines Immunotherap"},{"issue":"10","key":"10.1016\/j.amepre.2024.08.007_bib0036","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3390\/vaccines10101745","article-title":"Epidemiological characteristics of varicella under different immunisation strategies in Suzhou Prefecture, Jiangsu province","volume":"10","author":"Zhang","year":"2022","journal-title":"Vaccines"},{"issue":"20","key":"10.1016\/j.amepre.2024.08.007_bib0037","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1016\/j.vaccine.2020.01.087","article-title":"Impact of a 2-dose voluntary vaccination strategy on varicella epidemiology in Beijing, 2011-2017","volume":"38","author":"Suo","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2024.08.007_bib0038","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1017\/S0950268820000667","article-title":"The impact of long-term moderate level of vaccination coverage for epidemiology of varicella in Lu\u2019an, China: should we change immunisation strategy now?","volume":"148","author":"Qin","year":"2020","journal-title":"Epidemiology and Infection"},{"issue":"7","key":"10.1016\/j.amepre.2024.08.007_bib0039","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/vaccines10071010","article-title":"Prioritization of vaccines for inclusion into china\u2019s expanded program on immunization: evidence from experts\u2019 knowledge and opinions","volume":"10","author":"Ma","year":"2022","journal-title":"Vaccines"},{"issue":"10","key":"10.1016\/j.amepre.2024.08.007_bib0040","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jval.2018.08.005","article-title":"Economic analysis of vaccination programs","volume":"21","author":"Mauskopf","year":"2018","journal-title":"Value in Health"},{"issue":"27-28","key":"10.1016\/j.amepre.2024.08.007_bib0041","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.vaccine.2004.03.043","article-title":"An economic evaluation of varicella vaccination in Italian adolescents","volume":"22","author":"Thiry","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2024.08.007_bib0042","unstructured":"Shanghai Statistical Yearbook 2019. Shanghai Statistics Bureau website. https:\/\/tjj.sh.gov.cn\/tjnj\/20200427\/4aa08fba106d45fda6cb39817d961c98.html. Accessed March 30,2024"},{"issue":"2","key":"10.1016\/j.amepre.2024.08.007_bib0043","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/ijerph17020662","article-title":"Spatiotemporal Epidemiology of Varicella in Chongqing, China, 2014-2018","volume":"17","author":"Zhu","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.amepre.2024.08.007_bib0044","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/21645515.2020.1769395","article-title":"Epidemiology of varicella and effectiveness of varicella vaccine in Hangzhou, China, 2019","volume":"17","author":"Xu","year":"2021","journal-title":"Human Vaccines Immunotherap"},{"issue":"12","key":"10.1016\/j.amepre.2024.08.007_bib0045","first-page":"1048","article-title":"Analysis of protective effect of using chickenpox live attenuated vaccine among 4-17 years old children in Minhang district, Shanghai","volume":"48","author":"Du","year":"2014","journal-title":"Zhonghua yu fang yi xue za zhi [Chin J Prevent Med]"},{"issue":"38","key":"10.1016\/j.amepre.2024.08.007_bib0046","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1016\/j.vaccine.2018.08.004","article-title":"Effectiveness of post-exposure prophylaxis during varicella outbreaks among primary and middle school students in Shanghai: An analysis of three-year surveillance data","volume":"36","author":"Cao","year":"2018","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.amepre.2024.08.007_bib0047","first-page":"765","article-title":"Surveys on the immunization coverage of category\u2161vaccines among children aged 2\u223c7 years in Jinshan district of Shanghai","volume":"19","author":"Zhou","year":"2018","journal-title":"China Prevent Med"},{"issue":"1","key":"10.1016\/j.amepre.2024.08.007_bib0048","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s12879-018-3496-8","article-title":"Analysis of sero-epidemiological characteristics of varicella in healthy children in Jiangsu Province, China","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.amepre.2024.08.007_bib0049","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/INF.0b013e3181d7380e","article-title":"The Effectiveness of varicella vaccine in China","volume":"29","author":"Fu","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.amepre.2024.08.007_bib0050","first-page":"587","article-title":"Protective efficacy of varicella attenuated live vaccine for children in China: a Meta-analysis","volume":"18","author":"Zhu","year":"2017","journal-title":"China Prevent Med"},{"issue":"1","key":"10.1016\/j.amepre.2024.08.007_bib0051","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/s12879-021-06217-1","article-title":"Two-dose varicella vaccine effectiveness in China: a meta-analysis and evidence quality assessment","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"13","key":"10.1016\/j.amepre.2024.08.007_bib0052","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.vaccine.2011.01.037","article-title":"Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England","volume":"29","author":"van Hoek","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2024.08.007_bib0053","unstructured":"Shanghai Statistical Yearbook 2020. Shanghai Statistics Bureau website. https:\/\/tjj.sh.gov.cn\/tjnj_rkpc\/20220829\/29affc5f21a942cc8ab73a39e93c88f3.html. Accessed March 30,2024"},{"issue":"11","key":"10.1016\/j.amepre.2024.08.007_bib0054","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1017\/S0950268811002640","article-title":"The health and economic burden of chickenpox and herpes zoster in Belgium","volume":"140","author":"Bilcke","year":"2012","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.amepre.2024.08.007_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/00365548.2013.847529","article-title":"Cost-effectiveness analysis of varicella vaccine as post-exposure prophylaxis in Hong Kong","volume":"46","author":"Chui","year":"2014","journal-title":"Scand J Infect Dis"},{"issue":"10","key":"10.1016\/j.amepre.2024.08.007_bib0056","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/adc.88.10.862","article-title":"Varicella vaccination in England and Wales: cost-utility analysis","volume":"88","author":"Brisson","year":"2003","journal-title":"Arch Dis Childhood"},{"issue":"6","key":"10.1016\/j.amepre.2024.08.007_bib0057","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.vaccine.2011.11.026","article-title":"The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom","volume":"30","author":"van Hoek","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.amepre.2024.08.007_bib0058","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2471\/BLT.15.164418","article-title":"Cost-effectiveness thresholds: pros and cons","volume":"94","author":"Bertram","year":"2016","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.amepre.2024.08.007_bib0059","doi-asserted-by":"crossref","first-page":"E833","DOI":"10.1016\/S2214-109X(23)00162-6","article-title":"Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures","volume":"11","author":"Pichon-Riviere","year":"2023","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.amepre.2024.08.007_bib0060","unstructured":"China Health Statistics Yearbook 2021. Chinese government website. http:\/\/www.nhc.gov.cn\/mohwsbwstjxxzx\/tjtjnj\/202305\/304a301bfdb444afbf94b1a6c7f83bca.shtml. Accessed March 30,2024"},{"key":"10.1016\/j.amepre.2024.08.007_bib0061","unstructured":"China Statistical Yearbook. China National Bureau of Statistics website. https:\/\/www.stats.gov.cn\/sj\/ndsj\/. Accessed March 30,2024"},{"issue":"47","key":"10.1016\/j.amepre.2024.08.007_bib0062","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1016\/j.vaccine.2011.09.024","article-title":"Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program","volume":"29","author":"Tanuseputro","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.amepre.2024.08.007_bib0063","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vaccine.2013.11.008","article-title":"Different vaccination strategies in Spain and its impact on severe varicella and zoster","volume":"32","author":"Gil-Prieto","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.amepre.2024.08.007_bib0064","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.amepre.2023.05.007","article-title":"Cost-effectiveness of recombinant zoster vaccine for adults aged \u226550 years in China","volume":"65","author":"Jiang","year":"2023","journal-title":"Am J Prevent Med"},{"issue":"1","key":"10.1016\/j.amepre.2024.08.007_bib0065","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.amepre.2021.01.023","article-title":"Higher-valency pneumococcal conjugate vaccines: an exploratory cost-effectiveness analysis in US seniors","volume":"61","author":"Smith","year":"2021","journal-title":"Am J Prevent Med"},{"issue":"4","key":"10.1016\/j.amepre.2024.08.007_bib0066","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.clinthera.2015.01.006","article-title":"Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster","volume":"37","author":"Littlewood","year":"2015","journal-title":"Clin Therap"},{"issue":"4","key":"10.1016\/j.amepre.2024.08.007_bib0067","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1080\/21645515.2019.1672491","article-title":"Budget impact analysis of multiple varicella vaccination strategies: a Mexico perspective","volume":"16","author":"Graham","year":"2020","journal-title":"Human Vaccines Immunotherap"},{"issue":"2","key":"10.1016\/j.amepre.2024.08.007_bib0068","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.amepre.2018.09.020","article-title":"Cost Effectiveness of meningococcal serogroup b vaccination in college-aged young adults","volume":"56","author":"Leeds","year":"2019","journal-title":"Am J Prevent Med"},{"issue":"1","key":"10.1016\/j.amepre.2024.08.007_bib0069","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12916-018-1094-7","article-title":"The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study","volume":"16","author":"Melegaro","year":"2018","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.amepre.2024.08.007_bib0070","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2124784","article-title":"The health and economic impact of switching vaccines in universal varicella vaccination programs using a dynamic transmission model: an Israel case study","volume":"18","author":"Kujawski","year":"2022","journal-title":"Human Vaccines Immunotherap"},{"issue":"7","key":"10.1016\/j.amepre.2024.08.007_bib0071","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133606","article-title":"An assessment of the expected cost-effectiveness of quadrivalent influenza vaccines in Ontario, Canada using a static model","volume":"10","author":"Chit","year":"2015","journal-title":"Plos One"},{"issue":"2","key":"10.1016\/j.amepre.2024.08.007_bib0072","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/INF.0000000000002233","article-title":"Implementing universal varicella vaccination in Europe The Path Forward","volume":"38","author":"Spoulou","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"49","key":"10.1016\/j.amepre.2024.08.007_bib0073","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1016\/j.vaccine.2017.10.024","article-title":"Inclusion of the value of herd immunity in economic evaluations of vaccines. A systematic review of methods used","volume":"35","author":"Nymark","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2024.08.007_bib0074","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites - United States, 1995-2005","volume":"197","author":"Guris","year":"2008","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.amepre.2024.08.007_bib0075","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S0950268800004714","article-title":"Modelling the impact of immunization on the epidemiology of varicella zoster virus","volume":"125","author":"Brisson","year":"2000","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.1016\/j.amepre.2024.08.007_bib0076","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2268990","article-title":"Characteristics and economic burden of hospitalized patients with herpes zoster in China, before vaccination","volume":"19","author":"Chen","year":"2023","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10.1016\/j.amepre.2024.08.007_bib0077","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.puhe.2023.04.025","article-title":"Factors influencing herpes zoster vaccination among older people in China: results from a discrete choice experiment","volume":"220","author":"Zhang","year":"2023","journal-title":"Public Health"},{"issue":"1","key":"10.1016\/j.amepre.2024.08.007_bib0078","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210005","article-title":"Optimal gender-specific age for cost-effective vaccination with adjuvanted herpes zoster subunit vaccine in Chinese adults","volume":"14","author":"You","year":"2019","journal-title":"Plos One"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379724002733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379724002733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T14:36:31Z","timestamp":1734618991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379724002733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0749379724002733"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2024.08.007","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Varicella Vaccination for 1\u20134-Year-Olds in Shanghai, China","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2024.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}